electroCore (ECOR) Notes Payables (2017 - 2026)
electroCore (ECOR) posted Notes Payables of $1.0 million for Q2 2026, up 300.0% on a QoQ basis from $250000.0 in Q1 2026.
Analysis
electroCore (ECOR) Notes Payables (2017 - 2026) Analysis & Trends
electroCore has reported Notes Payables for 5 years, with the latest figure at $1.0 million in Q2 2026.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $311354.0, up 178.3% from the prior year.
- Notes Payables was $1.0 million for Q2 2026 at electroCore, up from $250000.0 in the prior quarter.
- The five-year high for Notes Payables was $1.0 million in Q2 2026, with the low at $250000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | electroCore | 87.36 Mn | 77.32 Mn | 8.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 250,000.00 |
| Mar 31, 2021 | 545,551.00 |
| Dec 31, 2020 | 311,354.00 |
| Sep 30, 2020 | 732,305.00 |
| Jun 30, 2020 | 552,410.00 |
| Dec 31, 2019 | 111,878.00 |
| Sep 30, 2019 | 461,341.00 |
| Dec 31, 2017 | 2.24 Mn |